Radiolabeling and in vivo evaluation of [11C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT7 receptor

Elina T. L’Estrade; Ida N. Petersen; Mengfei Xiong; Adam S. Hogendorf; Agata Hogendorf; Jesper L. Kristensen; Andreas Kjær; Andrzej J. Bojarski; Maria Erlandsson; Tomas Ohlsson; Gitte M. Knudsen; Matthias M. Herth

doi:10.1007/s10967-019-06687-3

Radiolabeling and in vivo evaluation of [¹¹C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT₇ receptor

Elina T. L’Estrade, Ida N. Petersen, Mengfei Xiong, Adam S. Hogendorf, Agata Hogendorf, Jesper L. Kristensen, Andreas Kjær, Andrzej J. Bojarski, Maria Erlandsson, Tomas Ohlsson, Gitte M. Knudsen, Matthias M. Herth^*

^*Corresponding author af dette arbejde

Abstract

AGH-44 is described as a selective low-basicity serotonin 7 receptor (5-HT₇R) agonist. In this paper, we evaluate if AGH-44 can act as a lead structure to develop a 5-HT₇R selective positron emission tomography (PET) tracer. ¹¹C-labeling of AGH-44 succeeded in a two-step, one-pot procedure in good yields. Subsequent PET studies showed that [¹¹C]AGH-44 displays low blood–brain-barrier passage in Long–Evans rats. Moreover, [¹¹C]AGH-44 brain accumulation showed to be independent on permeability glycoprotein (P-gp) efflux inhibition. Results from biodistribution and metabolism studies could neither explain the observed low brain uptake. As such, we believe that this scaffold is not an optimal starting point to develop a 5-HT₇R selective PET tracer.

Originalsprog	Engelsk
Tidsskrift	Journal of Radioanalytical and Nuclear Chemistry
Vol/bind	322
Udgave nummer	2
Sider (fra-til)	847-851
Antal sider	5
ISSN	0236-5731
DOI	https://doi.org/10.1007/s10967-019-06687-3
Status	Udgivet - 1 nov. 2019

Adgang til dokumentet

10.1007/s10967-019-06687-3

Andre filer og links

Link to publication in Scopus

Citationsformater

L’Estrade, E. T., Petersen, I. N., Xiong, M., Hogendorf, A. S., Hogendorf, A., Kristensen, J. L., Kjær, A., Bojarski, A. J., Erlandsson, M., Ohlsson, T., Knudsen, G. M., & Herth, M. M. (2019). Radiolabeling and in vivo evaluation of [¹¹C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT₇ receptor. Journal of Radioanalytical and Nuclear Chemistry, 322(2), 847-851. https://doi.org/10.1007/s10967-019-06687-3

Radiolabeling and in vivo evaluation of [¹¹C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT₇ receptor. / L’Estrade, Elina T.; Petersen, Ida N.; Xiong, Mengfei et al.
I: Journal of Radioanalytical and Nuclear Chemistry, Bind 322, Nr. 2, 01.11.2019, s. 847-851.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

L’Estrade, ET, Petersen, IN, Xiong, M, Hogendorf, AS, Hogendorf, A, Kristensen, JL , Kjær, A, Bojarski, AJ, Erlandsson, M, Ohlsson, T, Knudsen, GM & Herth, MM 2019, 'Radiolabeling and in vivo evaluation of [¹¹C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT₇ receptor', Journal of Radioanalytical and Nuclear Chemistry, bind 322, nr. 2, s. 847-851. https://doi.org/10.1007/s10967-019-06687-3

@article{889796bb9f654f0199f3e038832b93a9,

title = "Radiolabeling and in vivo evaluation of [11C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT7 receptor",

abstract = "AGH-44 is described as a selective low-basicity serotonin 7 receptor (5-HT7R) agonist. In this paper, we evaluate if AGH-44 can act as a lead structure to develop a 5-HT7R selective positron emission tomography (PET) tracer. 11C-labeling of AGH-44 succeeded in a two-step, one-pot procedure in good yields. Subsequent PET studies showed that [11C]AGH-44 displays low blood–brain-barrier passage in Long–Evans rats. Moreover, [11C]AGH-44 brain accumulation showed to be independent on permeability glycoprotein (P-gp) efflux inhibition. Results from biodistribution and metabolism studies could neither explain the observed low brain uptake. As such, we believe that this scaffold is not an optimal starting point to develop a 5-HT7R selective PET tracer.",

keywords = "5-HT, AGH-44, Carbon-11, PET",

author = "L{\textquoteright}Estrade, {Elina T.} and Petersen, {Ida N.} and Mengfei Xiong and Hogendorf, {Adam S.} and Agata Hogendorf and Kristensen, {Jesper L.} and Andreas Kj{\ae}r and Bojarski, {Andrzej J.} and Maria Erlandsson and Tomas Ohlsson and Knudsen, {Gitte M.} and Herth, {Matthias M.}",

year = "2019",

month = nov,

day = "1",

doi = "10.1007/s10967-019-06687-3",

language = "English",

volume = "322",

pages = "847--851",

journal = "Journal of Radioanalytical and Nuclear Chemistry",

issn = "0236-5731",

publisher = "Akad{\'e}miai Kiad{\'o}",

number = "2",

}

TY - JOUR

T1 - Radiolabeling and in vivo evaluation of [11C]AGH-44

T2 - a potential lead structure to develop a positron emission tomography radioligand for the 5-HT7 receptor

AU - L’Estrade, Elina T.

AU - Petersen, Ida N.

AU - Xiong, Mengfei

AU - Hogendorf, Adam S.

AU - Hogendorf, Agata

AU - Kristensen, Jesper L.

AU - Kjær, Andreas

AU - Bojarski, Andrzej J.

AU - Erlandsson, Maria

AU - Ohlsson, Tomas

AU - Knudsen, Gitte M.

AU - Herth, Matthias M.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - AGH-44 is described as a selective low-basicity serotonin 7 receptor (5-HT7R) agonist. In this paper, we evaluate if AGH-44 can act as a lead structure to develop a 5-HT7R selective positron emission tomography (PET) tracer. 11C-labeling of AGH-44 succeeded in a two-step, one-pot procedure in good yields. Subsequent PET studies showed that [11C]AGH-44 displays low blood–brain-barrier passage in Long–Evans rats. Moreover, [11C]AGH-44 brain accumulation showed to be independent on permeability glycoprotein (P-gp) efflux inhibition. Results from biodistribution and metabolism studies could neither explain the observed low brain uptake. As such, we believe that this scaffold is not an optimal starting point to develop a 5-HT7R selective PET tracer.

AB - AGH-44 is described as a selective low-basicity serotonin 7 receptor (5-HT7R) agonist. In this paper, we evaluate if AGH-44 can act as a lead structure to develop a 5-HT7R selective positron emission tomography (PET) tracer. 11C-labeling of AGH-44 succeeded in a two-step, one-pot procedure in good yields. Subsequent PET studies showed that [11C]AGH-44 displays low blood–brain-barrier passage in Long–Evans rats. Moreover, [11C]AGH-44 brain accumulation showed to be independent on permeability glycoprotein (P-gp) efflux inhibition. Results from biodistribution and metabolism studies could neither explain the observed low brain uptake. As such, we believe that this scaffold is not an optimal starting point to develop a 5-HT7R selective PET tracer.

KW - 5-HT

KW - AGH-44

KW - Carbon-11

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=85074379944&partnerID=8YFLogxK

U2 - 10.1007/s10967-019-06687-3

DO - 10.1007/s10967-019-06687-3

M3 - Journal article

AN - SCOPUS:85074379944

SN - 0236-5731

VL - 322

SP - 847

EP - 851

JO - Journal of Radioanalytical and Nuclear Chemistry

JF - Journal of Radioanalytical and Nuclear Chemistry

IS - 2